Publication:
The extracellular regulated kinase-1 (ERK1) controls regulated α-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein

dc.contributor.authorMoustapha Cisséen_US
dc.contributor.authorEric Duplanen_US
dc.contributor.authorMarie Victoire Guillot-Sestieren_US
dc.contributor.authorJoaquim Rumignyen_US
dc.contributor.authorCharlotte Baueren_US
dc.contributor.authorGilles Pagèsen_US
dc.contributor.authorHans Dieter Orzechowskien_US
dc.contributor.authorBarbara E. Slacken_US
dc.contributor.authorFrédéric Checleren_US
dc.contributor.authorBruno Vincenten_US
dc.contributor.otherUniversite Nice Sophia Antipolisen_US
dc.contributor.otherCharite - Universitatsmedizin Berlinen_US
dc.contributor.otherBoston University School of Medicineen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-05-03T08:00:55Z
dc.date.available2018-05-03T08:00:55Z
dc.date.issued2011-08-19en_US
dc.description.abstractThe α-secretases A disintegrin and metalloprotease 10 (ADAM10) and ADAM17 trigger constitutive and regulated processing of the cellular prion protein (PrPc) yielding N1 fragment. The latter depends on protein kinase C (PKC)-coupled M1/M3 muscarinic receptor activation and subsequent phosphorylation of ADAM17 on its intracytoplasmic threonine 735. Here we show that regulated PrPc processing and ADAM17 phosphorylation and activation are controlled by the extracellular-regulated kinase-1/MAP-ERK kinase (ERK1/MEK) cascade. Thus, reductions of ERK1 or MEK activities by dominantnegative analogs, pharmacological inhibition, or genetic ablation all impair N1 secretion, whereas constitutively active proteins increase N1 recovery in the conditioned medium. Interestingly, we also observed an ERK1-mediated enhanced expression of PrPc. We demonstrate that the ERK1-associated increase in PrPc promoter transactivation and mRNA levels involve transcription factor AP-1 as a downstream effector. Altogether, our data identify ERK1 as an important regulator of PrPc cellular homeostasis and indicate that this kinase exerts a dual control of PrPc levels through transcriptional and posttranscriptional mechanisms. © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.en_US
dc.identifier.citationJournal of Biological Chemistry. Vol.286, No.33 (2011), 29192-29206en_US
dc.identifier.doi10.1074/jbc.M110.208249en_US
dc.identifier.issn1083351Xen_US
dc.identifier.issn00219258en_US
dc.identifier.other2-s2.0-80051685988en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/11488
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80051685988&origin=inwarden_US
dc.subjectBiochemistry, Genetics and Molecular Biologyen_US
dc.titleThe extracellular regulated kinase-1 (ERK1) controls regulated α-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion proteinen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80051685988&origin=inwarden_US

Files

Collections